Nicolas Pages
Research Subjects
Nicolas Pages has a total of 65 co-authors. Here are the top co-authors by number of shared publications:
- Sophie Nisse Durgeat
NP Medical, Medical Affairs, 33000 Bordeaux, France
6 shared publications - Rémi Esser
Department of Cardiogeriatrics, Hôpital La Porte Verte, Versailles, France
5 shared publications Alejandro Mondragon
3 shared publicationsChristine Farges
3 shared publicationsMarc Harboun
3 shared publicationsMarine Larbaneix
3 shared publications
Latest Publications
- Open Access
- 7 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6933
Perceived Vaccination Knowledge and Self-Reported Uptake in a Nationwide Heart Failure Telemonitoring Cohort in France
Background/Objectives: Patients with heart failure (HF) are vulnerable to vaccine-preventable infections, yet vaccination data remain limited. We assessed perceived vaccination knowledge, attitudes, self-reported vaccine receipt, and variation by age, sex, region, and delivery pathway among digitally connected patients with HF enrolled in a nationwide telemonitoring program. Methods: This cross-sectional electronic survey was conducted from 5 to 28 November 2025, during the ongoing 2025–2026 influenza and COVID-19 vaccination campaigns, among app-connected Satelia® Cardio participants across France. Of 4856 invited app-connected patients, 1100 completed the questionnaire (response rate: 22.7%). Uptake of seasonal influenza and COVID-19 booster vaccination for the 2025–2026 season and lifetime receipt of pneumococcal, tetanus–diphtheria–pertussis–poliomyelitis (Tdap-polio), and herpes zoster vaccines were analyzed using Wilson 95% confidence intervals (CIs), age-adjusted logistic regression, and regional models adjusted for age and sex. Results: Respondents had a mean age of 71.5 years (SD: 12.6), and 718 (65.3%) were men. Overall, 87.5% considered vaccination useful, 96.0% knew where to be vaccinated, and 55.1% wanted telemonitoring-based reminders. Current-season reported vaccination was 62.2% for influenza and 31.4% for the COVID-19 booster, whereas lifetime self-reported receipt was 38.5% for Tdap-polio, 34.5% for pneumococcal vaccination, and 11.5% for herpes zoster. Influenza and COVID-19 uptake increased with age, whereas pneumococcal uptake peaked at 65–74 years. Pneumococcal receipt was higher in women than men (42.2% vs. 30.4%; age-adjusted odds ratio [aOR], 1.67; 95% confidence interval [CI], 1.29–2.17; p < 0.001). Community pharmacies delivered most influenza and COVID-19 vaccinations. Conclusions: Vaccination attitudes were favorable, while current-season vaccination and lifetime-reported vaccine receipt showed distinct patterns across age groups. These descriptive findings identify potential target groups for future telemonitoring-based preventive interventions, whose effectiveness requires prospective evaluation.
- 7 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (17) , 6933
Open AccessPerceived Vaccination Knowledge and Self-Reported Uptake in a Nationwide Heart Failure Telemonitoring Cohort in France
Background/Objectives: Patients with heart failure (HF) are vulnerable to vaccine-preventable infections, yet vaccination data remain limited. We assessed perceived vaccination knowledge, attitudes, self-reported vaccine receipt, and variation by age, sex, region, and delivery pathway among digitally connected patients with HF enrolled in a nationwide telemonitoring program. Methods: This cross-sectional electronic survey was conducted from 5 to 28 November 2025, during the ongoing 2025–2026 influenza and COVID-19 vaccination campaigns, among app-connected Satelia® Cardio participants across France. Of 4856 invited app-connected patients, 1100 completed the questionnaire (response rate: 22.7%). Uptake of seasonal influenza and COVID-19 booster vaccination for the 2025–2026 season and lifetime receipt of pneumococcal, tetanus–diphtheria–pertussis–poliomyelitis (Tdap-polio), and herpes zoster vaccines were analyzed using Wilson 95% confidence intervals (CIs), age-adjusted logistic regression, and regional models adjusted for age and sex. Results: Respondents had a mean age of 71.5 years (SD: 12.6), and 718 (65.3%) were men. Overall, 87.5% considered vaccination useful, 96.0% knew where to be vaccinated, and 55.1% wanted telemonitoring-based reminders. Current-season reported vaccination was 62.2% for influenza and 31.4% for the COVID-19 booster, whereas lifetime self-reported receipt was 38.5% for Tdap-polio, 34.5% for pneumococcal vaccination, and 11.5% for herpes zoster. Influenza and COVID-19 uptake increased with age, whereas pneumococcal uptake peaked at 65–74 years. Pneumococcal receipt was higher in women than men (42.2% vs. 30.4%; age-adjusted odds ratio [aOR], 1.67; 95% confidence interval [CI], 1.29–2.17; p < 0.001). Community pharmacies delivered most influenza and COVID-19 vaccinations. Conclusions: Vaccination attitudes were favorable, while current-season vaccination and lifetime-reported vaccine receipt showed distinct patterns across age groups. These descriptive findings identify potential target groups for future telemonitoring-based preventive interventions, whose effectiveness requires prospective evaluation.
- Open Access
- 17 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (16) , 2588
Patient-Reported Experience of Digital Remote Monitoring for Chronic Heart Failure Across Experimental and Routine Reimbursement Periods in France: Repeated Cross-Sectional Surveys of 1378 Users
Background/Objectives: In France, remote monitoring for chronic heart failure transitioned from the experimental ETAPES programme (Expérimentations de télémédecine pour l’amélioration des parcours de santé) to routine reimbursement in July 2023. Whether patient-reported experience remained similar during routine implementation in a real-world respondent population was unknown. This study compared satisfaction, usability, and perceived benefits among Satelia® Cardio users surveyed in 2020–2021 and 2024. Methods: This repeated cross-sectional study compared 978 adult users surveyed between August and December 2024 with 400 digitally literate users from the 2020–2021 reference cohort. Ten comparable items were analysed as the proportion selecting scores of 7–10. Differences were assessed using Pearson’s chi-square test with Yates’ continuity correction. Exploratory age-stratified analyses examined three usability items. Results: In 2024, 30.1% of respondents were aged ≥80 years. Overall satisfaction was similar (80.3% vs. 77.0%; p = 0.20). Two perception items showed higher unadjusted ratings: perceived improvement in treatment adherence (60.1% vs. 52.3%; +7.9 percentage points; p = 0.009) and perceived help to the treating physician (76.5% vs. 70.3%; +6.2 percentage points; p = 0.019); however, these findings remained exploratory after correction for multiplicity. Usability ratings were slightly lower in 2024, with the largest differences versus the aggregate 2021 reference among respondents aged ≥80 years; ratings among those aged ® Cardio were that telemonitoring was reassuring, useful and simple. Conclusions: During the routine-reimbursement period, satisfaction remained high in a respondent population in which 30.1% were aged ≥80 years. Two perception items showed higher unadjusted ratings, but these findings remained exploratory after correction for multiplicity. Descriptively lower usability ratings in the ≥80-year stratum warrant further evaluation and tailored support. Because the surveys involved independent, differently composed samples, causal and longitudinal conclusions cannot be drawn. These findings describe patient experience across two successive implementation contexts and should not be interpreted as evidence of a causal effect of reimbursement policy.
- 17 August 2026
- Published by MDPI AG in Healthcare
- Vol. 14 (16) , 2588
Open AccessPatient-Reported Experience of Digital Remote Monitoring for Chronic Heart Failure Across Experimental and Routine Reimbursement Periods in France: Repeated Cross-Sectional Surveys of 1378 Users
Background/Objectives: In France, remote monitoring for chronic heart failure transitioned from the experimental ETAPES programme (Expérimentations de télémédecine pour l’amélioration des parcours de santé) to routine reimbursement in July 2023. Whether patient-reported experience remained similar during routine implementation in a real-world respondent population was unknown. This study compared satisfaction, usability, and perceived benefits among Satelia® Cardio users surveyed in 2020–2021 and 2024. Methods: This repeated cross-sectional study compared 978 adult users surveyed between August and December 2024 with 400 digitally literate users from the 2020–2021 reference cohort. Ten comparable items were analysed as the proportion selecting scores of 7–10. Differences were assessed using Pearson’s chi-square test with Yates’ continuity correction. Exploratory age-stratified analyses examined three usability items. Results: In 2024, 30.1% of respondents were aged ≥80 years. Overall satisfaction was similar (80.3% vs. 77.0%; p = 0.20). Two perception items showed higher unadjusted ratings: perceived improvement in treatment adherence (60.1% vs. 52.3%; +7.9 percentage points; p = 0.009) and perceived help to the treating physician (76.5% vs. 70.3%; +6.2 percentage points; p = 0.019); however, these findings remained exploratory after correction for multiplicity. Usability ratings were slightly lower in 2024, with the largest differences versus the aggregate 2021 reference among respondents aged ≥80 years; ratings among those aged ® Cardio were that telemonitoring was reassuring, useful and simple. Conclusions: During the routine-reimbursement period, satisfaction remained high in a respondent population in which 30.1% were aged ≥80 years. Two perception items showed higher unadjusted ratings, but these findings remained exploratory after correction for multiplicity. Descriptively lower usability ratings in the ≥80-year stratum warrant further evaluation and tailored support. Because the surveys involved independent, differently composed samples, causal and longitudinal conclusions cannot be drawn. These findings describe patient experience across two successive implementation contexts and should not be interpreted as evidence of a causal effect of reimbursement policy.
- Open Access
- 20 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Determinants of Non-Enrolment in Heart Failure Telemonitoring Among Eligible Older Patients After Hospitalisation: A Real-World Cohort Study (Preprint)
BACKGROUND Remote monitoring reduces hospitalisations and mortality in selected patients with heart failure, but access among very old, frail patients in routine practice is poorly described. Non-enrolment may encompass distinct situations—including death, clinical ineligibility, referral to another pathway, patient refusal, and practical barriers—that should not be interpreted as a homogeneous outcome. OBJECTIVE To classify reasons for non-enrolment in a hospital-based telemonitoring pathway into meaningful categories, quantify non-enrolment among patients for whom enrolment was clinically relevant, and identify its determinants among these eligible patients. METHODS We conducted a retrospective, single-centre cohort study of 1386 patients hospitalised for heart failure in a cardiogeriatrics unit (TRIAGE-HF cohort; 16 December 2024 to 8 June 2026). Among 1063 patients not already telemonitored before admission, we classified the 451 not enrolled at discharge into six categories: death before a decision was possible, clinical/programme ineligibility, referral elsewhere, patient/family refusal, a potentially addressable practical or organisational barrier (including nursing home residence as a blanket exclusion), or uncertain eligibility. Patients with death, ineligibility, or referral elsewhere were excluded from the primary analysis. The primary outcome was non-enrolment among the 859 remaining eligible patients (612 newly enrolled, 247 not enrolled), assessed using a multivariable logistic regression model with a priori selected candidate variables; age was categorised to account for a detected non-linear association. RESULTS Among the 451 non-enrolled patients, 66 (14.6%) had died before a decision was possible, 84 (18.6%) were ineligible, 54 (12.0%) were referred elsewhere, 54 (12.0%) declined participation, 186 (41.2%) faced a practical/organisational barrier (132 with nursing home residence as the recorded reason), and 7 (1.6%) were undocumented. Among the 859 eligible patients, 247 (28.8%) were not enrolled. In the multivariable model (n=847, 240 events; age categorised because of a non-linear association), nursing home residence at admission was the strongest determinant (adjusted odds ratio [aOR] 30.00, 95% CI 15.01-59.93), followed by social isolation (aOR 3.46), depressive syndrome (aOR 1.73), and severe cognitive impairment (aOR 1.66); lower BMI and lower ADL score were also associated with non-enrolment. Age showed a non-monotonic pattern, with higher odds under 80 years (aOR 1.93) than at 80-89 years (reference) and no difference at 90 years or older. LVEF, NT-proBNP, atrial fibrillation/flutter, and Charlson index were not independently associated with non-enrolment (apparent AUC 0.830). Among 164 nursing home residents cohort-wide, only 34 (20.7%) were ever enrolled. CONCLUSIONS Once death, ineligibility, and referral elsewhere are separated out, and preference is distinguished from structural barriers, non-enrolment affects roughly three in ten eligible patients and is driven by nursing home residence, social isolation, depressive syndrome, and cognitive impairment rather than cardiac severity. Because most of this gap reflects potentially addressable practical or organisational barriers rather than documented patient or family refusal, adaptive, frailty-aware enrolment pathways for institutionalised patients warrant evaluation.
- 20 July 2026
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessDeterminants of Non-Enrolment in Heart Failure Telemonitoring Among Eligible Older Patients After Hospitalisation: A Real-World Cohort Study (Preprint)
BACKGROUND Remote monitoring reduces hospitalisations and mortality in selected patients with heart failure, but access among very old, frail patients in routine practice is poorly described. Non-enrolment may encompass distinct situations—including death, clinical ineligibility, referral to another pathway, patient refusal, and practical barriers—that should not be interpreted as a homogeneous outcome. OBJECTIVE To classify reasons for non-enrolment in a hospital-based telemonitoring pathway into meaningful categories, quantify non-enrolment among patients for whom enrolment was clinically relevant, and identify its determinants among these eligible patients. METHODS We conducted a retrospective, single-centre cohort study of 1386 patients hospitalised for heart failure in a cardiogeriatrics unit (TRIAGE-HF cohort; 16 December 2024 to 8 June 2026). Among 1063 patients not already telemonitored before admission, we classified the 451 not enrolled at discharge into six categories: death before a decision was possible, clinical/programme ineligibility, referral elsewhere, patient/family refusal, a potentially addressable practical or organisational barrier (including nursing home residence as a blanket exclusion), or uncertain eligibility. Patients with death, ineligibility, or referral elsewhere were excluded from the primary analysis. The primary outcome was non-enrolment among the 859 remaining eligible patients (612 newly enrolled, 247 not enrolled), assessed using a multivariable logistic regression model with a priori selected candidate variables; age was categorised to account for a detected non-linear association. RESULTS Among the 451 non-enrolled patients, 66 (14.6%) had died before a decision was possible, 84 (18.6%) were ineligible, 54 (12.0%) were referred elsewhere, 54 (12.0%) declined participation, 186 (41.2%) faced a practical/organisational barrier (132 with nursing home residence as the recorded reason), and 7 (1.6%) were undocumented. Among the 859 eligible patients, 247 (28.8%) were not enrolled. In the multivariable model (n=847, 240 events; age categorised because of a non-linear association), nursing home residence at admission was the strongest determinant (adjusted odds ratio [aOR] 30.00, 95% CI 15.01-59.93), followed by social isolation (aOR 3.46), depressive syndrome (aOR 1.73), and severe cognitive impairment (aOR 1.66); lower BMI and lower ADL score were also associated with non-enrolment. Age showed a non-monotonic pattern, with higher odds under 80 years (aOR 1.93) than at 80-89 years (reference) and no difference at 90 years or older. LVEF, NT-proBNP, atrial fibrillation/flutter, and Charlson index were not independently associated with non-enrolment (apparent AUC 0.830). Among 164 nursing home residents cohort-wide, only 34 (20.7%) were ever enrolled. CONCLUSIONS Once death, ineligibility, and referral elsewhere are separated out, and preference is distinguished from structural barriers, non-enrolment affects roughly three in ten eligible patients and is driven by nursing home residence, social isolation, depressive syndrome, and cognitive impairment rather than cardiac severity. Because most of this gap reflects potentially addressable practical or organisational barriers rather than documented patient or family refusal, adaptive, frailty-aware enrolment pathways for institutionalised patients warrant evaluation.
- Open Access
- 20 May 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e88681
Frailty-Based Remote Monitoring in Older Adults With Heart Failure: Conceptual Framework for Adaptive Digital Health Strategies
Remote monitoring is increasingly used in heart failure care, but most programs rely on uniform models that insufficiently reflect the heterogeneity of older adults, particularly with respect to frailty, cognitive impairment, functional dependency, and caregiver availability. This viewpoint argues that frailty should be considered a central determinant of remote monitoring design in older adults with heart failure, rather than a secondary modifier of conventional digital health pathways. Drawing on evidence from heart failure telemonitoring, geriatric medicine, and real-world cardiogeriatric experience, we propose a frailty-adaptive framework structured around four clinical trajectories: robust, prefrail, frail, and palliative. Each trajectory is associated with distinct monitoring objectives, workflow adaptations, and response pathways. Robust patients may benefit primarily from optimization, self-management support, and guideline-directed therapy titration; prefrail patients from early detection of deterioration and functional decline; frail patients from proxy-supported reporting, nurse-led triage, and rapid-access cardiogeriatric reassessment; and palliative patients from simplified symptom-guided monitoring focused on comfort, hospitalization avoidance, and caregiver support. This framework reframes remote monitoring as a stratified clinical process rather than a purely technological intervention. By aligning digital strategies with frailty status, functional capacity, and care goals, frailty-adaptive remote monitoring may improve clinical relevance, promote digital health equity, and support more sustainable models of care for older adults with heart failure.
- 20 May 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e88681
Open AccessFrailty-Based Remote Monitoring in Older Adults With Heart Failure: Conceptual Framework for Adaptive Digital Health Strategies
Remote monitoring is increasingly used in heart failure care, but most programs rely on uniform models that insufficiently reflect the heterogeneity of older adults, particularly with respect to frailty, cognitive impairment, functional dependency, and caregiver availability. This viewpoint argues that frailty should be considered a central determinant of remote monitoring design in older adults with heart failure, rather than a secondary modifier of conventional digital health pathways. Drawing on evidence from heart failure telemonitoring, geriatric medicine, and real-world cardiogeriatric experience, we propose a frailty-adaptive framework structured around four clinical trajectories: robust, prefrail, frail, and palliative. Each trajectory is associated with distinct monitoring objectives, workflow adaptations, and response pathways. Robust patients may benefit primarily from optimization, self-management support, and guideline-directed therapy titration; prefrail patients from early detection of deterioration and functional decline; frail patients from proxy-supported reporting, nurse-led triage, and rapid-access cardiogeriatric reassessment; and palliative patients from simplified symptom-guided monitoring focused on comfort, hospitalization avoidance, and caregiver support. This framework reframes remote monitoring as a stratified clinical process rather than a purely technological intervention. By aligning digital strategies with frailty status, functional capacity, and care goals, frailty-adaptive remote monitoring may improve clinical relevance, promote digital health equity, and support more sustainable models of care for older adults with heart failure.
- Open Access
- 1 May 2026
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 21, 1-16
Rehospitalisation Patterns in Very Old Adults with Heart Failure Managed Within an Integrated Cardiogeriatric Post-Discharge Care Pathway: The REACT-HF Study
Very old adults with heart failure (HF) experience high rehospitalisation rates related to multimorbidity, functional vulnerability, and complex care transitions. Empirical evidence on factors associated with rehospitalisation in very old adults with HF managed within integrated post-discharge care pathways remains limited. This study aimed to describe rehospitalisation patterns and associated clinical markers in very old patients with HF managed within an integrated cardiogeriatric post-discharge pathway. This retrospective single-centre cohort included patients aged ≥65 years hospitalised for acute HF and enrolled at discharge in an integrated cardiogeriatric pathway combining structured remote monitoring, rapid-access day-hospital services and coordinated outpatient follow-up (April 2023–August 2025). Analyses were restricted to patients who survived the early post-discharge period and had available 12-month follow-up data, in order to assess rehospitalisation status at predefined post-discharge time points. The primary outcome was unplanned HF rehospitalisation at 12 months; secondary outcomes included rehospitalisation at 3 and 6 months, predictors of rehospitalisation and hospital length of stay. Exploratory multivariable logistic regression analyses were performed. Among 255 very old patients with available 12-month follow-up data (median age 87 years), rehospitalisation rates were 9.8% at 3 months, 16.1% at 6 months and 24.7% at 12 months. Higher loop diuretic dose was associated with rehospitalisation at 3 months. At 6 months, moderate-to-severe mitral regurgitation, higher diuretic dose and absolute iron deficiency were independently associated with rehospitalisation. At 12 months, moderate-to-severe mitral regurgitation, iron deficiency and chronic obstructive pulmonary disease were independently associated. These findings apply to patients who survived the early post-discharge period and had sufficient follow-up data, rather than to an unselected acute HF population. In very old patients with HF and available longitudinal follow-up, higher loop diuretic dose, iron deficiency, moderate-to-severe mitral regurgitation, and COPD were associated with rehospitalisation status at predefined time horizons. These exploratory findings suggest that routinely available clinical markers may help support risk-stratified follow-up in advanced-age HF populations.
- 1 May 2026
- Published by Taylor & Francis in Clinical Interventions in Aging
- Vol. ume 21, 1-16
Open AccessRehospitalisation Patterns in Very Old Adults with Heart Failure Managed Within an Integrated Cardiogeriatric Post-Discharge Care Pathway: The REACT-HF Study
Very old adults with heart failure (HF) experience high rehospitalisation rates related to multimorbidity, functional vulnerability, and complex care transitions. Empirical evidence on factors associated with rehospitalisation in very old adults with HF managed within integrated post-discharge care pathways remains limited. This study aimed to describe rehospitalisation patterns and associated clinical markers in very old patients with HF managed within an integrated cardiogeriatric post-discharge pathway. This retrospective single-centre cohort included patients aged ≥65 years hospitalised for acute HF and enrolled at discharge in an integrated cardiogeriatric pathway combining structured remote monitoring, rapid-access day-hospital services and coordinated outpatient follow-up (April 2023–August 2025). Analyses were restricted to patients who survived the early post-discharge period and had available 12-month follow-up data, in order to assess rehospitalisation status at predefined post-discharge time points. The primary outcome was unplanned HF rehospitalisation at 12 months; secondary outcomes included rehospitalisation at 3 and 6 months, predictors of rehospitalisation and hospital length of stay. Exploratory multivariable logistic regression analyses were performed. Among 255 very old patients with available 12-month follow-up data (median age 87 years), rehospitalisation rates were 9.8% at 3 months, 16.1% at 6 months and 24.7% at 12 months. Higher loop diuretic dose was associated with rehospitalisation at 3 months. At 6 months, moderate-to-severe mitral regurgitation, higher diuretic dose and absolute iron deficiency were independently associated with rehospitalisation. At 12 months, moderate-to-severe mitral regurgitation, iron deficiency and chronic obstructive pulmonary disease were independently associated. These findings apply to patients who survived the early post-discharge period and had sufficient follow-up data, rather than to an unselected acute HF population. In very old patients with HF and available longitudinal follow-up, higher loop diuretic dose, iron deficiency, moderate-to-severe mitral regurgitation, and COPD were associated with rehospitalisation status at predefined time horizons. These exploratory findings suggest that routinely available clinical markers may help support risk-stratified follow-up in advanced-age HF populations.
- Open Access
- 22 August 2022
- Published by SAGE Publications in Digital Health
- Vol. 8
Remote patient monitoring for chronic heart failure in France: When an innovative funding program (ETAPES) meets an innovative solution (Satelia® Cardio)
Introduction: Remote patient monitoring (RPM) is a telehealth activity to collect and analyze patient health or medical data. Its use has expanded in the past decade and has improved medical outcomes and care management of non-communicable chronic diseases. However, implementation of RPM into routine clinical activities has been limited. The objective of this study was to describe the French funding program for RPM (known as ETAPES) and one of the RPM solution providers (Satelia®) dedicated to chronic heart failure (CHF). Methods: A descriptive assessment of both the ETAPES funding program and Satelia® RPM solution was conducted. Data were collected from official legal documents and information that was publicly available online from the French Ministry of Health. Results and Discussion: ETAPES was formally created in 2016 based on previous legislation pertaining to the national health insurance funding strategy. However, it only started to operate in 2018. Patients with CHF were only eligible if they were at medium or high risk of re-hospitalization with a New York Heart Association (NYHA) score superior or equal to two and a BNP>100 pg/ml or NT pro BNP>1000 pg/ml. Medical monitoring was supported through the therapeutic education of a patient on the RPM model of care with a minimum of three training sessions during the first six months. The use of Satelia® Cardio is noteworthy since it relies only on symptomatic monitoring through which the patient manually reports their information by answering a simple questionnaire on a regular basis and does not rely on any connected devices. Conclusion: Innovative funding programs and solutions for RPM need real-world evaluation in the future.
- 22 August 2022
- Published by SAGE Publications in Digital Health
- Vol. 8
Open AccessRemote patient monitoring for chronic heart failure in France: When an innovative funding program (ETAPES) meets an innovative solution (Satelia® Cardio)
Introduction: Remote patient monitoring (RPM) is a telehealth activity to collect and analyze patient health or medical data. Its use has expanded in the past decade and has improved medical outcomes and care management of non-communicable chronic diseases. However, implementation of RPM into routine clinical activities has been limited. The objective of this study was to describe the French funding program for RPM (known as ETAPES) and one of the RPM solution providers (Satelia®) dedicated to chronic heart failure (CHF). Methods: A descriptive assessment of both the ETAPES funding program and Satelia® RPM solution was conducted. Data were collected from official legal documents and information that was publicly available online from the French Ministry of Health. Results and Discussion: ETAPES was formally created in 2016 based on previous legislation pertaining to the national health insurance funding strategy. However, it only started to operate in 2018. Patients with CHF were only eligible if they were at medium or high risk of re-hospitalization with a New York Heart Association (NYHA) score superior or equal to two and a BNP>100 pg/ml or NT pro BNP>1000 pg/ml. Medical monitoring was supported through the therapeutic education of a patient on the RPM model of care with a minimum of three training sessions during the first six months. The use of Satelia® Cardio is noteworthy since it relies only on symptomatic monitoring through which the patient manually reports their information by answering a simple questionnaire on a regular basis and does not rely on any connected devices. Conclusion: Innovative funding programs and solutions for RPM need real-world evaluation in the future.
- 1 June 2021
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 40 (3) , 100879
Pain evaluation after day-surgery using a mobile phone application
- 1 June 2021
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 40 (3) , 100879
Pain evaluation after day-surgery using a mobile phone application
- Open Access
- 1 May 2021
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 28 (Supplement)
First experience with a ready-to-use solution for remote monitoring of patients suffering from heart failure
Funding Acknowledgements: Type of funding sources: None. Background: Heart failure (HF) is associated with a high mortality rate and recurrent hospitalizations. Purpose: To present the first data of the patients using Satelia® Cardio solution Method: Satelia® Cardio is a HF patient management solution with a remote monitoring system and a therapeutic guidance by a dedicated-nurse phone platform, supported by the ETAPES Program. The system is accessible from any device and requiring no installation. After the inclusion, the patient is contacted by the nurse, he then receives an SMS alerts following cardiologist prescription (on regular basis), with a link leading to a web page on which he will answer 7 questions and enter his current body weight. Satelia® Cardio algorithm is based on these data inputs, their variability, and the weight. In case of worsening of symptoms, the cardiologist will be notified. Since Covid-19 lockdown, more than 1400 patients have been monitored with the solution. Results: 165 centers (306 cardiologists) are using Satelia® Cardio with 3540 HF patients monitored in the last 29 months. The patients with a mean age of 72 years (19-100) are predominantly males (67%), and mostly NYHA II/III (69%/31%) with a mean LVEF of 40%. The adherence to the system is very good (91%) with 78% of patients still monitored (n = 2787). The main reasons for stopping are related to the occurrence of death (205/753) or patient/HCP decision (392/753), or other reasons (156/753). Over the period of analysis, the HF patients answered to 163 700 questionnaires, generating 8210 alerts transmitted to the referent cardiologists. Conclusion: Patient management solution with a remote monitoring system is key to improving the follow-up of HF patients. The solution Satelia® Cardio is an easy way to use a web application to monitor HF patients, especially on the current period of Covid-19 with a low rate of premature discontinuation. A further step will be to initiate studies to assess the potential benefits for both patients and HCPs of such remote monitoring solution in HF.
- 1 May 2021
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
- Vol. 28 (Supplement)
Open AccessFirst experience with a ready-to-use solution for remote monitoring of patients suffering from heart failure
Funding Acknowledgements: Type of funding sources: None. Background: Heart failure (HF) is associated with a high mortality rate and recurrent hospitalizations. Purpose: To present the first data of the patients using Satelia® Cardio solution Method: Satelia® Cardio is a HF patient management solution with a remote monitoring system and a therapeutic guidance by a dedicated-nurse phone platform, supported by the ETAPES Program. The system is accessible from any device and requiring no installation. After the inclusion, the patient is contacted by the nurse, he then receives an SMS alerts following cardiologist prescription (on regular basis), with a link leading to a web page on which he will answer 7 questions and enter his current body weight. Satelia® Cardio algorithm is based on these data inputs, their variability, and the weight. In case of worsening of symptoms, the cardiologist will be notified. Since Covid-19 lockdown, more than 1400 patients have been monitored with the solution. Results: 165 centers (306 cardiologists) are using Satelia® Cardio with 3540 HF patients monitored in the last 29 months. The patients with a mean age of 72 years (19-100) are predominantly males (67%), and mostly NYHA II/III (69%/31%) with a mean LVEF of 40%. The adherence to the system is very good (91%) with 78% of patients still monitored (n = 2787). The main reasons for stopping are related to the occurrence of death (205/753) or patient/HCP decision (392/753), or other reasons (156/753). Over the period of analysis, the HF patients answered to 163 700 questionnaires, generating 8210 alerts transmitted to the referent cardiologists. Conclusion: Patient management solution with a remote monitoring system is key to improving the follow-up of HF patients. The solution Satelia® Cardio is an easy way to use a web application to monitor HF patients, especially on the current period of Covid-19 with a low rate of premature discontinuation. A further step will be to initiate studies to assess the potential benefits for both patients and HCPs of such remote monitoring solution in HF.